Literature DB >> 11018607

Intensive medical management of ureteral calculi.

J T Cooper1, G M Stack, T P Cooper.   

Abstract

OBJECTIVES: To compare two treatment regimens in patients with ureteral calculi. One regimen (control arm) used routine drugs, and the second regimen (treatment arm) used the same routine drugs plus uncommonly used drugs.
METHODS: Between February and October 1998, 70 consecutive patients were evaluated for symptomatic ureteral calculi. Thirty-five patients were randomized to a control arm and received ketorolac, oxycodone, and acetaminophen combination tablets and prochlorperazine suppositories. Thirty-five patients were randomized to the treatment arm and received the same medications plus nifedipine XL, prednisone, and trimethoprim/sulfa combination tablets and plain acetaminophen. Stone passage rates, work days lost, emergency room visits, surgical interventions, and possible side effects of the drugs were recorded.
RESULTS: The treatment arm (addition of nifedipine XL, prednisone, trimethoprim/sulfa, and plain acetaminophen) had higher (86% versus 56%) stone passage rates and fewer lost work days (mean 1.76 versus 4.9), emergency room visits (1 versus 4), and surgical interventions (2 versus 15). Both arms exhibited similar potential drug side effects.
CONCLUSIONS: The addition of a calcium channel blocking agent, steroids, antibiotics, and more acetaminophen effected a higher stone passage rate and fewer lost work days, emergency room visits, and surgical interventions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018607     DOI: 10.1016/s0090-4295(00)00658-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  16 in total

Review 1.  Kidney stones.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2004-06-12

2.  Adjunctive therapy to promote stone passage.

Authors:  Geoffrey R Nuss; Judson D Rackley; Dean G Assimos
Journal:  Rev Urol       Date:  2005

Review 3.  Medical expulsive therapy for distal ureteral stones.

Authors:  Vassilios Tzortzis; Charalampos Mamoulakis; Jorge Rioja; Stavros Gravas; Martin C Michel; Jean J M C H de la Rosette
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Does tamsulosin change the management of proximally located ureteral stones?

Authors:  Faruk Yencilek; Sakip Erturhan; Onder Canguven; Hakan Koyuncu; Bulent Erol; Kemal Sarica
Journal:  Urol Res       Date:  2010-02-25

5.  The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics.

Authors:  Isao Wanajo; Yoshitaka Tomiyama; Mariko Tadachi; Mamoru Kobayashi; Yoshinobu Yamazaki; Masami Kojima; Nobuo Shibata
Journal:  Urol Res       Date:  2005-08-25

6.  Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones.

Authors:  Jian Lin Lv; Qing Lai Tang
Journal:  Urolithiasis       Date:  2014-08-20       Impact factor: 3.436

7.  The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?

Authors:  Riccardo Autorino; Marco De Sio; Rocco Damiano; Giuseppe Di Lorenzo; Sisto Perdonà; Aniello Russo; Giuseppe Quarto; Luca Cosentino; Massimo D'Armiento
Journal:  Urol Res       Date:  2005-11-29

8.  Tamsulosin versus Alfuzosin in the Treatment of Patients with Distal Ureteral Stones: Prospective, Randomized, Comparative Study.

Authors:  Abul-Fotouh Abdel-Maguid Ahmed; Abul-Yazid Saad Al-Sayed
Journal:  Korean J Urol       Date:  2010-03-19

9.  Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker--Tamsulosin.

Authors:  I Cervenàkov; J Fillo; J Mardiak; M Kopecný; J Smirala; P Lepies
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 10.  Medical therapy of stone disease: from prevention to promotion of passage options.

Authors:  Michael Lipkin; Ojas Shah
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.